Physiologic Effects of High-Dose Gastric Antral Botulinum Toxin Injections.

Trial Profile

Physiologic Effects of High-Dose Gastric Antral Botulinum Toxin Injections.

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Jan 2013

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Obesity
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Aug 2012 Actual end date (Sep 2011) added as reported by ClinicalTrials.gov.
    • 01 Apr 2011 Planned end date changed from Jun 2011 to Sep 2011 as reported by ClinicalTrials.gov.
    • 01 Apr 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top